Trial Profile
Evaluation of medication adherence of weekly DPP-4 inhibitor, trelagliptin in treating of type 2 diabetes mellitus
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2019
Price :
$35
*
At a glance
- Drugs Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 21 Aug 2017 Status changed from not yet recruiting to recruiting.
- 04 Feb 2017 New trial record